What are the necessary preoperative investigations for carcinoma of the vulva (Ca vulva)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Preoperative Investigations for Vulvar Carcinoma

For patients with vulvar carcinoma, preoperative investigations should include MRI of the pelvis without and with IV contrast for tumors >2 cm, and FDG-PET/CT from skull base to mid-thigh for tumors >4 cm or with significant involvement of adjacent structures. 1

Initial Assessment Based on Tumor Size and Invasion

Small Tumors (≤2 cm, ≤1 mm invasion)

  • Clinical examination alone is usually sufficient
  • Imaging typically not necessary 1
  • No lymph node evaluation required due to <1% risk of lymphatic metastases 1

Intermediate Tumors (≤4 cm, >1 mm invasion)

  • MRI pelvis without and with IV contrast - recommended to define extent of primary tumor and assess inguinofemoral lymph node (IFLN) basins 1
  • Consider vaginal gel during MRI to better delineate vaginal involvement 1
  • Lymph node evaluation required due to >8% risk of lymphatic metastases 1

Large/Advanced Tumors (>4 cm or significant involvement of adjacent structures)

  • MRI pelvis without and with IV contrast AND FDG-PET/CT from skull base to mid-thigh - both recommended and considered complementary for comprehensive staging 1
  • CT chest, abdomen, and pelvis with IV contrast - acceptable alternative if MRI unavailable 1

Lymph Node Assessment

For tumors >1 mm invasion:

  • Imaging assessment of inguinofemoral lymph nodes is critical as lymph node status is the most important prognostic factor 1, 2
  • For tumors <2 cm from midline: bilateral lymph node evaluation required 1
  • For tumors ≥2 cm from midline: unilateral lymph node evaluation on the same side as the tumor 1
  • Ultrasound with duplex Doppler and ultrasound-guided fine-needle aspiration biopsy may be appropriate to confirm suspected lymph node metastases 1

Special Considerations

Imaging Criteria for Lymph Node Metastasis

  • Short-axis to long-axis diameter ratio >0.75 has 86.7% sensitivity and 81.3% specificity 1
  • On CT, lymph nodes >10 mm in short-axis diameter and/or abnormal enhancement pattern suggest metastasis (60% sensitivity, 90% specificity) 1

Pitfalls to Avoid

  • Do not rely solely on clinical examination for lymph node assessment - has limited sensitivity
  • Do not omit imaging for tumors with >1 mm invasion, as depth of invasion correlates strongly with lymph node metastasis risk 2
  • Do not perform routine chest radiography - has limited value in initial staging and does not alter gynecologic management 1
  • Avoid unnecessary imaging for very small tumors (≤2 cm with ≤1 mm invasion) as the risk of lymph node metastasis is <1% 1

Follow-up After Initial Treatment

  • For suspected recurrence, consider:
    • Whole body PET/CT if not previously performed 1
    • Pelvic MRI to aid in treatment planning 1
    • CT chest, abdomen, and pelvis with IV contrast 1

The preoperative evaluation should be tailored according to tumor size, depth of invasion, and proximity to midline, with the primary goal of accurately assessing the extent of primary disease and lymph node status to guide appropriate surgical management and improve outcomes related to morbidity, mortality, and quality of life.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Vulvar Squamous Cell Carcinoma Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.